Selected research
Market Analysis & Forecast
Global Pathogen mNGS Detection Market Analysis and Forecast 2026-2032
Market perspective
The global Pathogen mNGS Detection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Pathogen mNGS Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Pathogen mNGS Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Pathogen mNGS Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Pathogen mNGS Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Pathogen mNGS Detection include BGI Genomics, Guangzhou Kingmed Diagnostics Group, Guangzhou Weiyuan Gene Technology, Capitalbio, Beijing Golden Key Gene Technology, IngeniGen, Difei Medical Technology, WillingMed Technology and Hangzhou Matridx Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Pathogen mNGS Detection, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Pathogen mNGS Detection, also provides the revenue of main regions and countries. Of the upcoming market potential for Pathogen mNGS Detection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pathogen mNGS Detection revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pathogen mNGS Detection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pathogen mNGS Detection revenue, projected growth trends, production technology, application and end-user industry.
Pathogen mNGS Detection Segment by Company
BGI Genomics
Guangzhou Kingmed Diagnostics Group
Guangzhou Weiyuan Gene Technology
Capitalbio
Beijing Golden Key Gene Technology
IngeniGen
Difei Medical Technology
WillingMed Technology
Hangzhou Matridx Biotechnology
Yuguo Biotechnology(Beijing)
Pathogen mNGS Detection Segment by Type
Technology Platform
Testing Service
Pathogen mNGS Detection Segment by Application
Hospital
Testing Facility
Other
Pathogen mNGS Detection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathogen mNGS Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pathogen mNGS Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathogen mNGS Detection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pathogen mNGS Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pathogen mNGS Detection company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pathogen mNGS Detection revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Technology Platform
- Testing Service
Applications
- Hospital
- Testing Facility
- Other
Companies covered
- BGI Genomics
- Guangzhou Kingmed Diagnostics Group
- Guangzhou Weiyuan Gene Technology
- Capitalbio
- Beijing Golden Key Gene Technology
- IngeniGen
- Difei Medical Technology
- WillingMed Technology
- Hangzhou Matridx Biotechnology
- Yuguo Biotechnology(Beijing)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Pathogen mNGS Detection Market by Type
- 1.2.1 Global Pathogen mNGS Detection Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Technology Platform
- 1.2.3 Testing Service
- 1.3 Pathogen mNGS Detection Market by Application
- 1.3.1 Global Pathogen mNGS Detection Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Testing Facility
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pathogen mNGS Detection Market Dynamics
- 2.1 Pathogen mNGS Detection Industry Trends
- 2.2 Pathogen mNGS Detection Industry Drivers
- 2.3 Pathogen mNGS Detection Industry Opportunities and Challenges
- 2.4 Pathogen mNGS Detection Industry Restraints
3 Global Growth Perspective
- 3.1 Global Pathogen mNGS Detection Market Perspective (2021-2032)
- 3.2 Global Pathogen mNGS Detection Growth Trends by Region
- 3.2.1 Global Pathogen mNGS Detection Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Pathogen mNGS Detection Market Size by Region (2021-2026)
- 3.2.3 Global Pathogen mNGS Detection Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Pathogen mNGS Detection Revenue by Players
- 4.1.1 Global Pathogen mNGS Detection Revenue by Players (2021-2026)
- 4.1.2 Global Pathogen mNGS Detection Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Pathogen mNGS Detection Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Pathogen mNGS Detection Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Pathogen mNGS Detection Key Players Headquarters & Area Served
- 4.4 Global Pathogen mNGS Detection Players, Product Type & Application
- 4.5 Global Pathogen mNGS Detection Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Pathogen mNGS Detection Market CR5 and HHI
- 4.6.3 2025 Pathogen mNGS Detection Tier 1, Tier 2, and Tier 3
5 Pathogen mNGS Detection Market Size by Type
- 5.1 Global Pathogen mNGS Detection Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Pathogen mNGS Detection Revenue by Type (2021-2032)
- 5.3 Global Pathogen mNGS Detection Revenue Market Share by Type (2021-2032)
6 Pathogen mNGS Detection Market Size by Application
- 6.1 Global Pathogen mNGS Detection Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Pathogen mNGS Detection Revenue by Application (2021-2032)
- 6.3 Global Pathogen mNGS Detection Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 BGI Genomics
- 7.1.1 BGI Genomics Company Information
- 7.1.2 BGI Genomics Business Overview
- 7.1.3 BGI Genomics Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
- 7.1.4 BGI Genomics Pathogen mNGS Detection Product Portfolio
- 7.1.5 BGI Genomics Recent Developments
- 7.2 Guangzhou Kingmed Diagnostics Group
- 7.2.1 Guangzhou Kingmed Diagnostics Group Company Information
- 7.2.2 Guangzhou Kingmed Diagnostics Group Business Overview
- 7.2.3 Guangzhou Kingmed Diagnostics Group Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
- 7.2.4 Guangzhou Kingmed Diagnostics Group Pathogen mNGS Detection Product Portfolio
- 7.2.5 Guangzhou Kingmed Diagnostics Group Recent Developments
- 7.3 Guangzhou Weiyuan Gene Technology
- 7.3.1 Guangzhou Weiyuan Gene Technology Company Information
- 7.3.2 Guangzhou Weiyuan Gene Technology Business Overview
- 7.3.3 Guangzhou Weiyuan Gene Technology Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
- 7.3.4 Guangzhou Weiyuan Gene Technology Pathogen mNGS Detection Product Portfolio
- 7.3.5 Guangzhou Weiyuan Gene Technology Recent Developments
- 7.4 Capitalbio
- 7.4.1 Capitalbio Company Information
- 7.4.2 Capitalbio Business Overview
- 7.4.3 Capitalbio Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
- 7.4.4 Capitalbio Pathogen mNGS Detection Product Portfolio
- 7.4.5 Capitalbio Recent Developments
- 7.5 Beijing Golden Key Gene Technology
- 7.5.1 Beijing Golden Key Gene Technology Company Information
- 7.5.2 Beijing Golden Key Gene Technology Business Overview
- 7.5.3 Beijing Golden Key Gene Technology Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
- 7.5.4 Beijing Golden Key Gene Technology Pathogen mNGS Detection Product Portfolio
- 7.5.5 Beijing Golden Key Gene Technology Recent Developments
- 7.6 IngeniGen
- 7.6.1 IngeniGen Company Information
- 7.6.2 IngeniGen Business Overview
- 7.6.3 IngeniGen Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
- 7.6.4 IngeniGen Pathogen mNGS Detection Product Portfolio
- 7.6.5 IngeniGen Recent Developments
- 7.7 Difei Medical Technology
- 7.7.1 Difei Medical Technology Company Information
- 7.7.2 Difei Medical Technology Business Overview
- 7.7.3 Difei Medical Technology Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
- 7.7.4 Difei Medical Technology Pathogen mNGS Detection Product Portfolio
- 7.7.5 Difei Medical Technology Recent Developments
- 7.8 WillingMed Technology
- 7.8.1 WillingMed Technology Company Information
- 7.8.2 WillingMed Technology Business Overview
- 7.8.3 WillingMed Technology Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
- 7.8.4 WillingMed Technology Pathogen mNGS Detection Product Portfolio
- 7.8.5 WillingMed Technology Recent Developments
- 7.9 Hangzhou Matridx Biotechnology
- 7.9.1 Hangzhou Matridx Biotechnology Company Information
- 7.9.2 Hangzhou Matridx Biotechnology Business Overview
- 7.9.3 Hangzhou Matridx Biotechnology Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
- 7.9.4 Hangzhou Matridx Biotechnology Pathogen mNGS Detection Product Portfolio
- 7.9.5 Hangzhou Matridx Biotechnology Recent Developments
- 7.10 Yuguo Biotechnology(Beijing)
- 7.10.1 Yuguo Biotechnology(Beijing) Company Information
- 7.10.2 Yuguo Biotechnology(Beijing) Business Overview
- 7.10.3 Yuguo Biotechnology(Beijing) Pathogen mNGS Detection Revenue and Gross Margin (2021-2026)
- 7.10.4 Yuguo Biotechnology(Beijing) Pathogen mNGS Detection Product Portfolio
- 7.10.5 Yuguo Biotechnology(Beijing) Recent Developments
8 North America
- 8.1 North America Pathogen mNGS Detection Revenue (2021-2032)
- 8.2 North America Pathogen mNGS Detection Revenue by Type (2021-2032)
- 8.2.1 North America Pathogen mNGS Detection Revenue by Type (2021-2026)
- 8.2.2 North America Pathogen mNGS Detection Revenue by Type (2027-2032)
- 8.3 North America Pathogen mNGS Detection Revenue Share by Type (2021-2032)
- 8.4 North America Pathogen mNGS Detection Revenue by Application (2021-2032)
- 8.4.1 North America Pathogen mNGS Detection Revenue by Application (2021-2026)
- 8.4.2 North America Pathogen mNGS Detection Revenue by Application (2027-2032)
- 8.5 North America Pathogen mNGS Detection Revenue Share by Application (2021-2032)
- 8.6 North America Pathogen mNGS Detection Revenue by Country
- 8.6.1 North America Pathogen mNGS Detection Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Pathogen mNGS Detection Revenue by Country (2021-2026)
- 8.6.3 North America Pathogen mNGS Detection Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Pathogen mNGS Detection Revenue (2021-2032)
- 9.2 Europe Pathogen mNGS Detection Revenue by Type (2021-2032)
- 9.2.1 Europe Pathogen mNGS Detection Revenue by Type (2021-2026)
- 9.2.2 Europe Pathogen mNGS Detection Revenue by Type (2027-2032)
- 9.3 Europe Pathogen mNGS Detection Revenue Share by Type (2021-2032)
- 9.4 Europe Pathogen mNGS Detection Revenue by Application (2021-2032)
- 9.4.1 Europe Pathogen mNGS Detection Revenue by Application (2021-2026)
- 9.4.2 Europe Pathogen mNGS Detection Revenue by Application (2027-2032)
- 9.5 Europe Pathogen mNGS Detection Revenue Share by Application (2021-2032)
- 9.6 Europe Pathogen mNGS Detection Revenue by Country
- 9.6.1 Europe Pathogen mNGS Detection Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Pathogen mNGS Detection Revenue by Country (2021-2026)
- 9.6.3 Europe Pathogen mNGS Detection Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Pathogen mNGS Detection Revenue (2021-2032)
- 10.2 China Pathogen mNGS Detection Revenue by Type (2021-2032)
- 10.2.1 China Pathogen mNGS Detection Revenue by Type (2021-2026)
- 10.2.2 China Pathogen mNGS Detection Revenue by Type (2027-2032)
- 10.3 China Pathogen mNGS Detection Revenue Share by Type (2021-2032)
- 10.4 China Pathogen mNGS Detection Revenue by Application (2021-2032)
- 10.4.1 China Pathogen mNGS Detection Revenue by Application (2021-2026)
- 10.4.2 China Pathogen mNGS Detection Revenue by Application (2027-2032)
- 10.5 China Pathogen mNGS Detection Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Pathogen mNGS Detection Revenue (2021-2032)
- 11.2 Asia Pathogen mNGS Detection Revenue by Type (2021-2032)
- 11.2.1 Asia Pathogen mNGS Detection Revenue by Type (2021-2026)
- 11.2.2 Asia Pathogen mNGS Detection Revenue by Type (2027-2032)
- 11.3 Asia Pathogen mNGS Detection Revenue Share by Type (2021-2032)
- 11.4 Asia Pathogen mNGS Detection Revenue by Application (2021-2032)
- 11.4.1 Asia Pathogen mNGS Detection Revenue by Application (2021-2026)
- 11.4.2 Asia Pathogen mNGS Detection Revenue by Application (2027-2032)
- 11.5 Asia Pathogen mNGS Detection Revenue Share by Application (2021-2032)
- 11.6 Asia Pathogen mNGS Detection Revenue by Country
- 11.6.1 Asia Pathogen mNGS Detection Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Pathogen mNGS Detection Revenue by Country (2021-2026)
- 11.6.3 Asia Pathogen mNGS Detection Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Pathogen mNGS Detection Revenue (2021-2032)
- 12.2 SAMEA Pathogen mNGS Detection Revenue by Type (2021-2032)
- 12.2.1 SAMEA Pathogen mNGS Detection Revenue by Type (2021-2026)
- 12.2.2 SAMEA Pathogen mNGS Detection Revenue by Type (2027-2032)
- 12.3 SAMEA Pathogen mNGS Detection Revenue Share by Type (2021-2032)
- 12.4 SAMEA Pathogen mNGS Detection Revenue by Application (2021-2032)
- 12.4.1 SAMEA Pathogen mNGS Detection Revenue by Application (2021-2026)
- 12.4.2 SAMEA Pathogen mNGS Detection Revenue by Application (2027-2032)
- 12.5 SAMEA Pathogen mNGS Detection Revenue Share by Application (2021-2032)
- 12.6 SAMEA Pathogen mNGS Detection Revenue by Country
- 12.6.1 SAMEA Pathogen mNGS Detection Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Pathogen mNGS Detection Revenue by Country (2021-2026)
- 12.6.3 SAMEA Pathogen mNGS Detection Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst